Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs)

被引:29
|
作者
Fischer, JA [1 ]
Muff, R [1 ]
Born, W [1 ]
机构
[1] Univ Zurich, Res Lab Calcium Metab, Dept Orthopaed Surg & Med, Klin Balgrist, CH-8008 Zurich, Switzerland
关键词
adrenomedullin; calcitonin-gene-related peptide; calcitonin receptor; calcitonin-receptor-like receptor; heterodimeric complex;
D O I
10.1042/bst0300455
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The calcitonin (CT) receptor (CTR) and the CTR-like receptor (CRLR) are close relatives within the type 11 family of G-protein-coupled receptors, demonstrating sequence identity of 50%. Unlike the interaction between CT and CTR, receptors for the related hormones and neuropeptides amylin, CT-gene-related peptide (CGRP) and adrenomedullin (AM) require one of three accessory receptor-activity-modifying proteins (RAMPs) for ligand recognition. An amylin/CGRP receptor is revealed when CTR is co-expressed with RAMP1. When complexed with RAMP3, CTR interacts with amylin alone. CRLR, initially classed as an orphan receptor, is a CGRP receptor when co-expressed with RAMP1. The same receptor is specific for AM in the presence of RAMP2. Together with human RAMP3, CRLR defines an AM receptor, and with mouse RAMP3 it is a low-affinity CGRP/AM receptor. CTR-RAMP1, antagonized preferentially by salmon CT-(8-32) and not by CGRP-(8-37), and CRLR-RAMP1, antagonized by CGRP-(8-37), are two CGRP receptor isotypes. Thus amylin and CGRP interact specifically with heterodimeric complexes between CTR and RAMP1 or RAMP3, and CGRP and AM interact with complexes between CRLR and RAMP1, RAMP2 or RAMP3.
引用
收藏
页码:455 / 460
页数:6
相关论文
共 48 条
  • [1] Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor
    Armour, SL
    Foord, S
    Kenakin, T
    Chen, WJ
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1999, 42 (04) : 217 - 224
  • [2] Receptor activity-modifying proteins; multifunctional G protein-coupled receptor accessory proteins
    Hay, Debbie L.
    Walker, Christopher S.
    Gingell, Joseph J.
    Ladds, Graham
    Reynolds, Christopher A.
    Poyner, David R.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 568 - 573
  • [3] Functional interaction of g protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP)
    Born, W
    Muff, R
    Fischer, JA
    MICROSCOPY RESEARCH AND TECHNIQUE, 2002, 57 (01) : 14 - 22
  • [4] Receptor activity modifying proteins
    Sexton, PM
    Albiston, A
    Morfis, M
    Tilakaratne, N
    CELLULAR SIGNALLING, 2001, 13 (02) : 73 - 83
  • [5] Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins
    Kikumoto, K
    Katafuchi, T
    Minamino, N
    HYPERTENSION RESEARCH, 2003, 26 : S15 - S23
  • [6] Expression of calcitonin receptor-like receptor and receptor-activity-modifying proteins in human cranial arteries
    Sams, A
    Jansen-Olesen, I
    NEUROSCIENCE LETTERS, 1998, 258 (01) : 41 - 44
  • [7] Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles
    Hay, Debbie L.
    Pioszak, Augen A.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56, 2016, 56 : 469 - 487
  • [8] Adrenomedullin (AM) and receptor-activity-modifying proteins in glomeruli with Thy.1 glomerulonephritis
    Matsumoto M.
    Fujimoto S.
    Iwatsubo S.
    Sato Y.
    Hara S.
    Kitamura K.
    Eto T.
    Journal of Clinical and Experimental Nephrology, 2004, 8 (4): : 316 - 321
  • [9] Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins
    Kotliar, Ilana B.
    Lorenzen, Emily
    Schwenk, Jochen M.
    Hay, Debbie L.
    Sakmar, Thomas P.
    PHARMACOLOGICAL REVIEWS, 2023, 75 (01) : 1 - 34
  • [10] Aspartate69 of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2
    Ittner, LM
    Luessi, F
    Koller, D
    Born, W
    Fischer, JA
    Muff, R
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 319 (04) : 1203 - 1209